Chronic migraine

被引:192
|
作者
Schwedt, Todd J. [1 ]
机构
[1] Mayo Clin, Phoenix, AZ 85054 USA
来源
关键词
MEDICATION OVERUSE HEADACHE; QUALITY STANDARDS SUBCOMMITTEE; STATE FUNCTIONAL CONNECTIVITY; PERIPHERAL-NERVE STIMULATION; DEFINING REFRACTORY MIGRAINE; EVIDENCE-BASED GUIDELINES; PLACEBO-CONTROLLED PHASE; EPISODIC MIGRAINE; DOUBLE-BLIND; TRANSFORMED MIGRAINE;
D O I
10.1136/bmj.g1416
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine. Chronic migraine places an enormous burden on patients owing to frequent headaches; hypersensitivity to visual, auditory, and olfactory stimuli; nausea; and vomiting. It also affects society through direct and indirect medical costs. Chronic migraine typically develops after a slow increase in headache frequency over months to years. Several factors are associated with an increased risk of transforming to chronic migraine. The diagnosis requires a carefully performed patient interview and neurologic examination, sometimes combined with additional diagnostic tests, to differentiate chronic migraine from secondary headache disorders and other primary chronic headaches of long duration. Treatment takes a multifaceted approach that may include risk factor modification, avoidance of migraine triggers, drug and non-drug based prophylaxis, and abortive migraine treatment, the frequency of which is limited to avoid drug overuse. This article provides an overview of current knowledge regarding chronic migraine, including epidemiology, risk factors for its development, pathophysiology, diagnosis, management, and guidelines. The future of chronic migraine treatment and research is also discussed.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Emerging treatment for chronic migraine and refractory chronic migraine
    Lionetto, Luana
    Negro, Andrea
    Palmisani, Stefano
    Gentile, Giovanna
    Del Fiore, Maria Rosaria
    Mercieri, Marco
    Simmaco, Maurizio
    Smith, Thomas
    Al-Kaisy, Adnan
    Arcioni, Roberto
    Martelletti, Paolo
    EXPERT OPINION ON EMERGING DRUGS, 2012, 17 (03) : 393 - 406
  • [2] Chronic migraine
    Olesen, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E457 - E457
  • [3] Chronic migraine
    Valade, D.
    REVUE NEUROLOGIQUE, 2013, 169 (05) : 419 - 426
  • [4] Chronic migraine
    Valade, D.
    DOULEUR ET ANALGESIE, 2010, 23 (03): : 151 - 158
  • [5] Chronic migraine
    Diener, H. C.
    Holle, D.
    Mueller, D.
    Naegel, S.
    Rabe, K.
    NERVENARZT, 2013, 84 (12): : 1460 - 1466
  • [6] Chronic daily headache: Transformational migraine, chronic migraine, and related disorders
    Joel R. Saper
    Current Neurology and Neuroscience Reports, 2008, 8 : 100 - 107
  • [7] Chronic daily headache: Transformational migraine, chronic migraine, and related disorders
    Saper, Joel R.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2008, 8 (02) : 100 - 107
  • [8] Refractory migraine and chronic migraine: Pathophysiological mechanisms
    Goadsby, Peter J.
    Hargreaves, Richard
    HEADACHE, 2008, 48 (06): : 799 - 804
  • [9] Exercise in Treatment of Migraine Including Chronic Migraine
    Tae-Jin Song
    Min Kyung Chu
    Current Pain and Headache Reports, 2021, 25
  • [10] Chronic migraine is the earlier stage of migraine chronification
    Bigal, ME
    Rapoport, AM
    Sheftell, FD
    Tepper, SJ
    Lipton, RB
    CEPHALALGIA, 2005, 25 (10) : 936 - 936